Transitions Supportive Care Llc | |
1669 Mahan Center Blvd Tallahassee FL 32308-5454 | |
(850) 878-5310 | |
Not Available |
Full Name | Transitions Supportive Care Llc |
---|---|
Speciality | Family Medicine |
Location | 1669 Mahan Center Blvd, Tallahassee, Florida |
Authorized Official Name and Position | Kimberly Baxa (DIRECTOR OF REVENUE CYCLE) |
Authorized Official Contact | 7029602272 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Transitions Supportive Care Llc 1669 Mahan Center Blvd Tallahassee FL 32308-5454 Ph: (850) 878-5310 | Transitions Supportive Care Llc 1669 Mahan Center Blvd Tallahassee FL 32308-5454 Ph: (850) 878-5310 |
NPI Number | 1861149080 |
---|---|
Provider Enumeration Date | 03/08/2022 |
Last Update Date | 03/08/2022 |
Certification Date | 03/08/2022 |
Medicare PECOS PAC ID | 7214301209 |
---|---|
Medicare Enrollment ID | O20230314001596 |
News Archive
A large multicentre trial seems finally to have resolved one of IVF's long-running controversies - whether the outlook for women with a poor IVF record can be improved by routine hysteroscopy performed before further IVF treatment.
Researchers have identified somatic mutations in the brain that could contribute to the development of Alzheimer's disease. Their findings were published in the journal Nature Communications last week.
Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) announces an increase to the size of its non-brokered private placement to a total of approximately 2.27 million units (the "Units") at a price of $0.55 per Unit, from the previously announced total of approximately 1.8 million Units, each Unit comprised of one Common Share of the Corporation and one-half of one Common Share purchase warrant ("Warrant") with each whole Warrant entitling the holder to purchase an additional Common Share ("Warrant Share") at a price of $0.80 per Warrant Share for a term of thirty-six (36) months following the date of issuance, for gross proceeds of up to $1.25 million (the "Offering").
The U.S. Food and Drug Administration today published a new regulation defining the term "gluten-free" for voluntary food labeling. This will provide a uniform standard definition to help the up to 3 million Americans who have celiac disease, an autoimmune digestive condition that can be effectively managed only by eating a gluten free diet.
› Verified 3 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1861149080 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (* (Not Available)) | Secondary |
207QH0002X | Family Medicine - Hospice And Palliative Medicine | (* (Not Available)) | Primary |
Provider Name | Kathleen Reid |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1437400298 PECOS PAC ID: 4880817733 Enrollment ID: I20140521001090 |
News Archive
A large multicentre trial seems finally to have resolved one of IVF's long-running controversies - whether the outlook for women with a poor IVF record can be improved by routine hysteroscopy performed before further IVF treatment.
Researchers have identified somatic mutations in the brain that could contribute to the development of Alzheimer's disease. Their findings were published in the journal Nature Communications last week.
Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) announces an increase to the size of its non-brokered private placement to a total of approximately 2.27 million units (the "Units") at a price of $0.55 per Unit, from the previously announced total of approximately 1.8 million Units, each Unit comprised of one Common Share of the Corporation and one-half of one Common Share purchase warrant ("Warrant") with each whole Warrant entitling the holder to purchase an additional Common Share ("Warrant Share") at a price of $0.80 per Warrant Share for a term of thirty-six (36) months following the date of issuance, for gross proceeds of up to $1.25 million (the "Offering").
The U.S. Food and Drug Administration today published a new regulation defining the term "gluten-free" for voluntary food labeling. This will provide a uniform standard definition to help the up to 3 million Americans who have celiac disease, an autoimmune digestive condition that can be effectively managed only by eating a gluten free diet.
› Verified 3 days ago
Provider Name | Martha Kelly Waldrep Reeves |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1801371430 PECOS PAC ID: 0143559997 Enrollment ID: I20190904002358 |
News Archive
A large multicentre trial seems finally to have resolved one of IVF's long-running controversies - whether the outlook for women with a poor IVF record can be improved by routine hysteroscopy performed before further IVF treatment.
Researchers have identified somatic mutations in the brain that could contribute to the development of Alzheimer's disease. Their findings were published in the journal Nature Communications last week.
Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) announces an increase to the size of its non-brokered private placement to a total of approximately 2.27 million units (the "Units") at a price of $0.55 per Unit, from the previously announced total of approximately 1.8 million Units, each Unit comprised of one Common Share of the Corporation and one-half of one Common Share purchase warrant ("Warrant") with each whole Warrant entitling the holder to purchase an additional Common Share ("Warrant Share") at a price of $0.80 per Warrant Share for a term of thirty-six (36) months following the date of issuance, for gross proceeds of up to $1.25 million (the "Offering").
The U.S. Food and Drug Administration today published a new regulation defining the term "gluten-free" for voluntary food labeling. This will provide a uniform standard definition to help the up to 3 million Americans who have celiac disease, an autoimmune digestive condition that can be effectively managed only by eating a gluten free diet.
› Verified 3 days ago
Provider Name | Haley R Davis |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1720719503 PECOS PAC ID: 4385007897 Enrollment ID: I20230831001774 |
News Archive
A large multicentre trial seems finally to have resolved one of IVF's long-running controversies - whether the outlook for women with a poor IVF record can be improved by routine hysteroscopy performed before further IVF treatment.
Researchers have identified somatic mutations in the brain that could contribute to the development of Alzheimer's disease. Their findings were published in the journal Nature Communications last week.
Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) announces an increase to the size of its non-brokered private placement to a total of approximately 2.27 million units (the "Units") at a price of $0.55 per Unit, from the previously announced total of approximately 1.8 million Units, each Unit comprised of one Common Share of the Corporation and one-half of one Common Share purchase warrant ("Warrant") with each whole Warrant entitling the holder to purchase an additional Common Share ("Warrant Share") at a price of $0.80 per Warrant Share for a term of thirty-six (36) months following the date of issuance, for gross proceeds of up to $1.25 million (the "Offering").
The U.S. Food and Drug Administration today published a new regulation defining the term "gluten-free" for voluntary food labeling. This will provide a uniform standard definition to help the up to 3 million Americans who have celiac disease, an autoimmune digestive condition that can be effectively managed only by eating a gluten free diet.
› Verified 3 days ago
News Archive
A large multicentre trial seems finally to have resolved one of IVF's long-running controversies - whether the outlook for women with a poor IVF record can be improved by routine hysteroscopy performed before further IVF treatment.
Researchers have identified somatic mutations in the brain that could contribute to the development of Alzheimer's disease. Their findings were published in the journal Nature Communications last week.
Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) announces an increase to the size of its non-brokered private placement to a total of approximately 2.27 million units (the "Units") at a price of $0.55 per Unit, from the previously announced total of approximately 1.8 million Units, each Unit comprised of one Common Share of the Corporation and one-half of one Common Share purchase warrant ("Warrant") with each whole Warrant entitling the holder to purchase an additional Common Share ("Warrant Share") at a price of $0.80 per Warrant Share for a term of thirty-six (36) months following the date of issuance, for gross proceeds of up to $1.25 million (the "Offering").
The U.S. Food and Drug Administration today published a new regulation defining the term "gluten-free" for voluntary food labeling. This will provide a uniform standard definition to help the up to 3 million Americans who have celiac disease, an autoimmune digestive condition that can be effectively managed only by eating a gluten free diet.
› Verified 3 days ago
Seasons Of Life Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 113 S Monroe St, Tallahassee, FL 32301 Phone: 850-201-7177 Fax: 850-201-7101 | |
Tallahassee Neurology Associates, P.a. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2868 Mahan Dr, Suite 5, Tallahassee, FL 32308 Phone: 850-942-7177 Fax: 850-656-9443 | |
Psychiatry Associates Of Tallahassee, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1407 M D Ln Ste A, Tallahassee, FL 32308 Phone: 850-877-0635 Fax: 850-205-0195 | |
Dna Comprehensive Therapy Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1965 Capital Cir Ne Ste 102, Tallahassee, FL 32308 Phone: 850-671-4600 | |
Renewing Minds Counseling And Consulting Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4047 Ailanthus Ct, Tallahassee, FL 32305 Phone: 850-692-9268 | |
Dr. Peter Debelius-enemark, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1407 M D Ln Ste A, Tallahassee, FL 32308 Phone: 850-877-0635 Fax: 850-205-0195 | |
Tallahassee Therapy Associates, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 109 W 4th Ave, Tallahassee, FL 32303 Phone: 850-241-5707 |